TADACIP №4

What is TADACIP No. 4?

TADACIP No. 4 is a pharmaceutical drug for men used for erectile dysfunction, which is the persistent or recurrent inability to achieve and maintain an erection sufficient for sexual intercourse. The product belongs to the pharmacological group of phosphodiesterase type 5 inhibitors. Its action is aimed at improving blood flow to the corpora cavernosa of the penis in response to sexual stimulation. The drug does not cause an erection automatically and does not increase sexual desire.

TADACIP No. 4 is manufactured in the form of tablets for oral administration. The designation "No. 4" means that the package contains four tablets, and the dosage of the active substance is typically 20 mg in each tablet. This format can be convenient for episodic use as needed. Before use, it is necessary to check the dosage, composition, and information on the original packaging.

The manufacturer of TADACIP No. 4 is the pharmaceutical company Cipla. The drug is positioned as a product based on tadalafil, the active substance also used in the original brand Cialis. The therapeutic effect of tadalafil can last up to 36 hours, but this does not mean a continuous erection throughout the entire period. The duration and intensity of action depend on health status, concomitant diseases, and individual body response.

What is TADACIP No. 4 prescribed for?

The main indication for the use of TADACIP No. 4 is erectile dysfunction in adult men. Tadalafil helps to achieve an erection in the presence of natural sexual arousal and maintain it for the time necessary for sexual intercourse. The drug can be used for erectile dysfunction of vascular, psychogenic, or mixed origin after a medical examination. It does not eliminate the direct cause of the disorder, so it is important to evaluate cardiovascular, hormonal, and psychological factors.

Tadalafil is also used for the symptoms of benign prostatic hyperplasia, particularly difficult urination, weak urine stream, and frequent nighttime urges. However, for this indication, a different, lower daily dose is usually used, rather than a 20 mg tablet as needed. Splitting the tablet or changing the treatment regimen on your own is not recommended. The appropriate regimen is determined by a urologist after evaluating symptoms and concomitant therapy.

TADACIP No. 4 is not intended to increase sexual stamina in men without erectile dysfunction. The product does not treat infertility, premature ejaculation, or sexually transmitted infections. A doctor's consultation is mandatory before starting use, especially in the presence of heart disease or ongoing medical treatment. The specialist must ensure that sexual activity and the use of the PDE-5 inhibitor are safe.

Composition and active components of TADACIP No. 4

The active component of TADACIP No. 4 is tadalafil in a dose of 20 mg. It selectively inhibits the enzyme phosphodiesterase type 5, abbreviated as PDE-5, and increases the level of cyclic guanosine monophosphate in tissues. In simple terms, this helps to relax the smooth muscles of the vessels and increase blood flow to the penis. The mechanism is realized only after the release of nitric oxide during sexual stimulation.

The composition of the tablets also includes auxiliary components that form the core and coating, ensure stability, and proper release of tadalafil. Their exact list must be verified in the official instructions of the specific batch, as it may include fillers, binders, colorants, and film coating components. Excipients do not provide a therapeutic effect but may be important for patients with allergies or intolerance to individual compounds. In the presence of known hypersensitivity, the composition should be agreed upon with a doctor or pharmacist.

Dosage of TADACIP No. 4

For adult men, the standard starting dose of tadalafil when used as needed is often 10 mg prior to anticipated sexual activity. If the effect is insufficient and the drug is well tolerated, the doctor may recommend 20 mg, which corresponds to the dosage of one tablet of TADACIP No. 4. The maximum frequency of administration is once a day, regardless of the duration of the effect. The 20 mg dose is not intended for continuous daily use without a specific recommendation from a specialist.

The duration of treatment is determined individually and depends on the causes of erectile dysfunction, the effectiveness, and tolerability of the therapy. For a regular daily regimen, the doctor may choose tadalafil in a dose of 2.5 or 5 mg, rather than TADACIP No. 4 of 20 mg. Patients with impaired renal or hepatic function may need a dose reduction or discontinuation of the drug. Elderly age by itself does not always require adjustment, but concomitant diseases and other medications must be taken into account.

How to take TADACIP No. 4 correctly?

The tablet of TADACIP No. 4 is swallowed whole, washed down with a sufficient amount of water, approximately at least 30 minutes before sexual activity. The drug can be taken regardless of food intake, as it usually has no clinically significant effect on the absorption of tadalafil. The onset of action and its intensity may vary from man to man. Sexual stimulation is necessary to obtain the effect.

For episodic use, the concept of a missed dose has no practical significance: do not take a double amount of tablets. If the drug is prescribed on a regular schedule, actions in case of a missed dose must be agreed with a doctor. You should not combine TADACIP No. 4 with other remedies for erection or increase the dose on your own. Before taking it, you must inform your doctor about all diseases, supplements, and medications being used.

Side effects of TADACIP No. 4

Common adverse reactions of TADACIP No. 4 include headache, hot flashes, nasal congestion, dyspepsia, back pain, and muscle aches. Dizziness, palpitations, reflux, nausea, or abdominal discomfort are possible. Usually, such symptoms are mild or moderate in nature and pass on their own. The individual reaction of the body may vary, so even typical side effects do not occur in every patient.

Immediate medical attention is required for chest pain, fainting, severe shortness of breath, sudden deterioration of vision or hearing. A dangerous condition is priapism — a painful erection lasting more than four hours, as delay can damage the tissues of the penis. Rarely, severe allergic reactions with swelling of the face, tongue, or difficulty breathing are possible. In case of chest pain after tadalafil, you must not take nitrates on your own; the healthcare provider should be informed of the time of the last dose.

Contraindications of TADACIP No. 4

TADACIP No. 4 is contraindicated in case of allergy to tadalafil or auxiliary components, as well as with the simultaneous use of any organic nitrates. It must not be combined with guanylate cyclase stimulators, including riociguat, due to the risk of a dangerous drop in blood pressure. The drug is not used if sexual activity is not recommended due to severe cardiovascular disease. Recent myocardial infarction or stroke, unstable angina, uncontrolled arrhythmia, severe hypotension, or hypertension require special evaluation.

Caution is necessary in case of anatomical deformation of the penis, predisposition to priapism, peptic ulcer disease, bleeding disorders, severe kidney or liver diseases. TADACIP No. 4 is not intended for children and adolescents under 18 years of age, as well as for women, so the issue of pregnancy and breastfeeding is not an applicable indication for this drug. Elderly men require an evaluation of general condition, blood pressure, and drug interactions. The final decision on the safety of administration must be made by a doctor.

Interaction of TADACIP No. 4 with other drugs and alcohol

The most dangerous interaction is that of TADACIP No. 4 with nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, and other nitrates, as a critical drop in blood pressure is possible. Caution is required when using alpha-blockers, antihypertensive drugs, strong inhibitors or inducers of hepatic enzymes, certain antifungal, antiviral, and anticonvulsant agents. It is not recommended to combine tadalafil with sildenafil, vardenafil, or other drugs for the treatment of erectile dysfunction. A complete list of medications must be provided to the doctor before starting therapy.

Excessive alcohol consumption while taking TADACIP No. 4 increases the risk of dizziness, rapid heartbeat, headache, and orthostatic hypotension, which is a drop in blood pressure when standing up. A small amount of alcohol does not always cause an interaction, but it is safest to limit or avoid alcoholic beverages. Tadalafil usually does not directly affect the ability to drive vehicles. If dizziness, visual impairment, or weakness occur, driving and operating machinery should be postponed.

Where to buy TADACIP No. 4 in Ukraine

TADACIP No. 4 in Ukraine should be purchased only in licensed pharmacies or verified pharmacy services, where you can get information about the origin, batch, expiration date, and dispensing conditions of the drug. The availability and legal status of a specific package should be clarified before ordering, as offers may vary. Upon receiving delivery, it is necessary to check the integrity of the packaging, the marking of the manufacturer Cipla, and the presence of instructions. You should not buy tablets without the original packaging or at a suspiciously low price due to the risk of counterfeiting.

Store TADACIP No. 4 in its original packaging, in a dry place, protected from light and out of reach of children, observing the temperature specified in the instructions. Do not use the drug after the expiration date or if the tablet or blister is damaged. Delivery conditions should exclude overheating, excessive humidity, and violation of packaging integrity. Before taking TADACIP No. 4, a doctor's consultation is necessary, as efficacy, tolerability, and the risk of side effects are individual.